PATENT CLAIM ANALYSIS

Application Number: 15981503
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "018400"]

Abstract:
The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their activity.

Claim (Index 8):
The method, according to  claim 3 , comprising administering a unit dose of from 2 mg to 50 mg of the acetate salt of SEQ ID NO:13.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.17391
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14056496', '14872975', '15046325', '11658061', '15614047']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.684968794421344
- 35 USC 102 Novelty (BERT): 0.503203027028847
- Combined Prediction Score: 0.6667922176820943
- Mean Citation Score: 181.05273
- Max Citation Score: 199.59079
- Similarity Product: 129.49329418869257

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test